MSD supports the global campaign against HIV and is present during AIDS2018

MSD proudly joins the HIV Prevention Campaign and the Global HIV Community to support "Not Measurable = Non-transferable" (undetectable = non-transferable, abbreviation U = U). The campaign aims to reduce the stigma associated with living with HIV

An HIV-positive person who takes the right medication and whose virus has not been measurably present for more than six months can not transmit the virus. MSD announced its support for the campaign on the eve of the International AIDS Conference in Amsterdam (23-27 July 2018). The MSD pharmaceutical company has been conducting research on HIV treatment for over thirty years.

The campaign launched an unprecedented and meaningful movement that must change the perception and understanding of HIV in a positive direction. "Non-measurable = non-transferable" is internationally supported by more than 695 organizations in 90 countries, including HIV Vereniging Nederland, V & VN Nursing HIV Consultants and the Dutch Association of HIV Treatment Practitioners. The international movement is led by Bruce Richman on behalf of the Prevention Access Campaign (PAC)

Unmeasurable = Non-transferable

An HIV-positive person who takes the right medication and has not had the virus present for more than six months, the virus can not transfer. U = U means Undetectable = Untransmittable. In Dutch: Not measurable = Not transferable. The PARTNER study has shown that you can not transmit HIV if you receive a combination treatment successfully and that you therefore have an undetectable "viral load" (amount of HIV in your body). The risk of transfer is negligible in terms of effective treatment and is not relevant in practice. Even if you have sex without a condom. In sex without a condom, you remain at risk for other STDs. The study included 1166 couples in which an HIV-free partner had sex with a partner with HIV whose virus was suppressed by HIV inhibitors

AIDS2018

All organizations active in HIV / AIDS HIV and AIDS are called next week Approximately 18,000 doctors, researchers and people living with HIV from around the world are welcome at the International AIDS Conference in Amsterdam. Of course, MSD is also present at AIDS2018 (July 23-27, 2018)

MSD has been involved in HIV treatment research for more than 30 years. "Thanks in part to the efforts of people like Irving Sigal, in 1996 – when I started MSD myself – we treated the fact that people had no longer to die from the effects of AIDS ". der Linde, operator in the MSD Specialties department in Haarlem. "In many cases, HIV / AIDS has gone from a fatal disease to a chronic disease.We pack these drugs here and I think it's something very special …"

Anno 2018, MSD is still supporting projects in different parts of the world on prevention, treatment, care and support for people living with HIV. "While tremendous progress has been made in the fight against HIV / AIDS, the ongoing scientific innovation is necessary given the unmet need that exists in HIV," he says. . George Hanna, Vice President and Chief Therapist for Infectious Diseases, Global Clinical Development. MSD will present data on ongoing Phase 3 research during AIDS2018.